BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 308835)

  • 1. Activity-dependent changes in substantia nigra gamma-aminobutyric acid.
    Swift RM; Hoffmann PC; Heller A
    Brain Res; 1978 Nov; 156(1):181-6. PubMed ID: 308835
    [No Abstract]   [Full Text] [Related]  

  • 2. The turnover rate of gamma-aminobutyric acid in the substantia nigra following electrical stimulation or lesioning of the strionigral pathways.
    Mao CC; Peralta E; Morini F; Costa E
    Brain Res; 1978 Oct; 155(1):147-52. PubMed ID: 688008
    [No Abstract]   [Full Text] [Related]  

  • 3. GABAergic denervation of rat substantia nigra: functional and pharmacological properties.
    Gale K; Iadarola MJ
    Brain Res; 1980 Feb; 183(1):217-23. PubMed ID: 6244049
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of content with synthesis, uptake and breakdown of GABA in substantia nigra of unoperated, hemitransected and kainate-treated rats.
    Starr M; Kilpatrick I
    Life Sci; 1981 Nov; 29(22):2281-7. PubMed ID: 7321760
    [No Abstract]   [Full Text] [Related]  

  • 5. Accommodation of rat nigrostriatal dopamine neurones to high frequency electrical stimulation of the median forebrain bundle: in vivo voltammetric data.
    Stamford JA; Kruk ZL; Millar J
    Neurosci Lett; 1987 Nov; 82(2):172-6. PubMed ID: 3501081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
    Straughan DW; James TA
    Int J Neurol; 1979; 13(1-4):81-93. PubMed ID: 122391
    [No Abstract]   [Full Text] [Related]  

  • 7. A quantitative study of cell death in the substantia nigra following a mechanical lesion of the medial forebrain bundle.
    Brecknell JE; Dunnett SB; Fawcett JW
    Neuroscience; 1995 Jan; 64(1):219-27. PubMed ID: 7708207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic neurons: simultaneous measurements of dopamine release and single-unit activity during stimulation of the medial forebrain bundle.
    Kuhr WG; Wightman RM; Rebec GV
    Brain Res; 1987 Aug; 418(1):122-8. PubMed ID: 3499205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of specific brain lesions on the high affinity binding of GABA in the substantia nigra.
    Kupersmith MJ; Lieberman AN
    Brain Res; 1980 Aug; 194(2):536-9. PubMed ID: 6248173
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional interaction between rat substantia nigra and striatum: GABA and dopamine interrelation.
    Racagni G; Bruno F; Cattabeni F; Maggi A; Di Giulio AM; Parenti M; Groppetti A
    Brain Res; 1977 Oct; 134(2):353-8. PubMed ID: 890495
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stereotyped behavior and the nigro-strio-nigral system].
    Arushanian EB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
    [No Abstract]   [Full Text] [Related]  

  • 12. Memory facilitation by self-stimulation reinforcement mediated by the nigro-neostriatal bundle.
    Major R; White N
    Physiol Behav; 1978 Jun; 20(6):723-33. PubMed ID: 308234
    [No Abstract]   [Full Text] [Related]  

  • 13. The striatum and substantia nigra: a commentary on their relationships.
    Dray A
    Neuroscience; 1979; 4(10):1407-39. PubMed ID: 233319
    [No Abstract]   [Full Text] [Related]  

  • 14. Is the striato-nigral pathway responsible for 'feed-back' control of dopamine release [proceedings]?
    Arbuthnott GW; Garcia-Munoz M; Nicolaou NM; Tulloch IF; Wright AK
    Br J Pharmacol; 1976 Oct; 58(2):272P. PubMed ID: 974393
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term decreases in spontaneous firing of caudate neurons induced by amphetamine in cats.
    Levine MS; Hull CD; Garcia-Rill E; Erinoff L; Buchwald NA; Heller A
    Brain Res; 1980 Jul; 194(1):263-8. PubMed ID: 6247037
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra.
    Saavedra JM; Setler PE; Kebabian JW
    Brain Res; 1978 Aug; 151(2):339-52. PubMed ID: 679013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms contributing to the recovery of striatal releasable dopamine following MFB stimulation.
    Michael AC; Ikeda M; Justice JB
    Brain Res; 1987 Sep; 421(1-2):325-35. PubMed ID: 3500755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.